Lv62
2410 积分 2022-09-22 加入
Unaddressed Methodological Heterogeneities in the Assessment of HCC Risk After HBsAg Seroclearance
17天前
已完结
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events
17天前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
17天前
已完结
Discovery of a first-in-class orally available HBV cccDNA inhibitor
18天前
已完结
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
18天前
已完结
Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy
18天前
已完结
中华医学会肺癌临床诊疗指南（2025版）
25天前
已完结
丙型肝炎防治指南（2019年版）
28天前
已关闭
皖公网安备34019202002308
